PharmaShots Weekly Snapshots (Mar 15 – 19, 2021)

Takeda Collaborates with Anima to Discover and Develop mRNA Translation Modulators for Neurological Diseases

Published: Mar 19, 2021 | Tags: Takeda, Collaborates, Anima, Discover, Develop, mRNA Translation Modulators, Neurological Diseases

Kiniksa’s Arcalyst (rilonacept) Receives the US FDA’s Approval for the Treatment of Pericarditis

Published: Mar 19, 2021 | Tags: Kiniksa, Arcalyst (rilonacept), Receives, US, FDA, Approval, Treatment, Pericarditis

Sarepta Therapeutics Report Results of SRP-9003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2E

Published: Mar 19, 2021 | Tags: Sarepta Therapeutics, Report, Results, SRP-9003, Treatment, Limb-Girdle Muscular Dystrophy Type 2E

Pfizer Signs a WW License Agreement with Pyxis to Develop and Commercialize Two ADC Candidates

Published: Mar 19, 2021 | Tags: Pfizer, Signs, WW, License Agreement, Pyxis, Develop, Commercialize, Two ADC Candidates

Boston Signs Out-License and Option Agreement with GSK to Advance Two Programs for Oncology and CNS Disorders

Published: Mar 19, 2021 | Tags: Boston, Signs, Out-License, Option Agreement, GSK, Advance, Two Programs, Oncology, CNS Disorders

Gilead Expands its Collaboration with Novo Nordisk to Evaluate Triple Combination Regimen for Compensated Cirrhosis (F4) due to NASH

Published: Mar 19, 2021 | Tags: Gilead, Expands, Collaboration, Novo Nordisk, Evaluate, Triple Combination Regimen, Compensated, Cirrhosis (F4), NASH

GSK Initiates P-III Study of GSK3511294 (GSK’294) for the Treatment of Severe Asthma

Published: Mar 18, 2021 | Tags: GSK, Initiates, P-III, Study, GSK3511294 (GSK’294), Treatment, Severe Asthma

Merck’s Keytruda (pembrolizumab) Receives the EC’s Approval in Adults & Pediatric patients with R/R cHL

Published: Mar 18, 2021 | Tags: Merck, Keytruda (pembrolizumab), Receives, EC, Approval, Adults & Pediatric patients, R/R cHL

FSD Pharma Signs a License Agreement with Innovet to Develop Veterinary Drugs for Gastro-Intestinal Diseases in Dogs and Cats

Published: Mar 18, 2021 | Tags: FSD Pharma, Signs, License Agreement, Innovet, Develop, Veterinary Drugs, Gastro-Intestinal, Diseases

Merck Signs a Five-Year Agreement with M2GEN to Advance Cancer Therapies

Published: Mar 18, 2021 | Tags: Merck, Signs, Five-Year, Agreement, M2GEN, Advance, Cancer Therapies

WuXi Biologics to Acquire Pfizer’s Biologics Manufacturing Facilities in China

Published: Mar 18, 2021 | Tags: WuXi Biologics, Acquire, Pfizer, Biologics, Manufacturing Facilities, China

Merck Collaborates with Amathus Therapeutics to Develop Treatments for Neurodegenerative Diseases

Published: Mar 18, 2021 | Tags: Merck, Collaborates, Amathus Therapeutics, Develop, Treatments, Neurodegenerative Diseases

NCCN Collaborates with Pfizer for New Biosimilars Research Projects in Oncology

Published: Mar 17, 2021 | Tags: NCCN, Collaborates, Pfizer, New, Biosimilars, Research Projects, Oncology

Johnson & Johnson Report Long-Term Data of Tremfya (guselkumab) in P-III DISCOVER-2 Study for Active Psoriatic Arthritis

Published: Mar 17, 2021 | Tags: Johnson & Johnson, Report, Long-Term Data, Tremfya (guselkumab), P-III DISCOVER-2, Study, Active, Psoriatic Arthritis

FibroGen Initiates P-III LELANTOS-2 Study of Pamrevlumab for Duchenne Muscular Dystrophy

Published: Mar 17, 2021 | Tags: FibroGen, Initiates, P-III LELANTOS-2, Study, Pamrevlumab, Duchenne Muscular Dystrophy

Sanofi Out Licenses Two Sickle Cell Disease Programs to GBT for $353M

Published: Mar 17, 2021 | Tags: Sanofi, Out Licenses, Two Sickle Cell Disease Programs, GBT, $353M

Lilly Reports Results of Mirikizumab in P-III LUCENT-1 Induction Study for Ulcerative Colitis

Published: Mar 17, 2021 | Tags: Lilly, Reports, Results, Mirikizumab, P-III LUCENT-1, Induction Study, Ulcerative Colitis

GSK and Medicago Initiate P-III Trial for Adjuvanted COVID-19 Vaccine Candidate

Published: Mar 17, 2021 | Tags: GSK and Medicago, Initiate, P-III Trial, Adjuvanted, COVID-19 Vaccine Candidate

Merck Reports the US FDA’s Acceptance of NDA for Priority Review of Belzutifan (MK-6482) to Treat Patients with Von Hippel-Lindau Disease Associated RCC

Published: Mar 16, 2021 | Tags: Merck, Reports, US, FDA, Acceptance, NDA, Priority Review, Belzutifan (MK-6482),Treat, Patients, Von Hippel-Lindau Disease Associated RCC

Genentech Reports Two-Year Data of Evrysdi (risdiplam) for People with Type 2 or Type 3 SMA

Published: Mar 16, 2021 | Tags: Genentech, Reports, Two-Year Data, Evrysdi (risdiplam), People, Type 2 or Type 3 SMA

Roche Launches Cobas SARS-CoV-2 Variant Test to Detect Emerging Coronavirus Mutations

Published: Mar 16, 2021 | Tags: Roche, Launches, Cobas SARS-CoV-2 Variant Test, Detect, Emerging, Coronavirus, Mutations

Novartis and Molecular Partners Report Inclusion of Ensovibep (MP0420) in NIH-Sponsored ACTIV-3 Trial for the Treatment of COVID 19

Published: Mar 16, 2021 | Tags: Novartis and Molecular Partners, Report, Inclusion, Ensovibep (MP0420), NIH-Sponsored, ACTIV-3 Trial, Treatment, COVID 19

Gilead Collaborates with Merck to Jointly Develop and Commercialize Lenacapavir + Islatravir for HIV

Published: Mar 16, 2021 | Tags: Gilead, Collaborates, Merck, Jointly, Develop, Commercialize, Lenacapavir, Islatravir, HIV

Takeda Signs a License Agreement with Genevant to Develop Novel Nucleic Acid Therapeutics for Liver Fibrosis

Published: Mar 16, 2021 | Tags: Takeda, Signs, License Agreement, Genevant, Develop, Novel, Nucleic Acid, Therapeutics, Liver Fibrosis

BioXcel’s BXCL501 Receives the US FDA’s Breakthrough Therapy Designation for Acute Treatment of Agitation Associated with Dementia

Published: Mar 15, 2021 | Tags: BioXcel, BXCL501, Receives, US, FDA, Breakthrough Therapy Designation, Acute, Treatment, Agitation, Associated, Dementia

Cardinal Health to Divest its Cordis Business to Hellman & Friedman for $1B

Published: Mar 15, 2021 | Tags: Cardinal Health, Divest, Cordis Business, Hellman & Friedman, $1B

BMS Collaborates with Aveo to Evaluate Opdivo (nivolumab) + Fotivda (tivozanib) in P-III Study for Relapsed Renal Cell Carcinoma

Published: Mar 15, 2021 | Tags: BMS, Collaborates, Aveo, Evaluate, Opdivo (nivolumab), Fotivda (tivozanib), P-III Study, Relapsed Renal Cell Carcinoma

Roche to Acquire GenMark Diagnostics for $1.8B

Published: Mar 15, 2021 | Tags: Roche, Acquire, GenMark Diagnostics, $1.8B

Regeneron and Sanofi Report Results of Libtayo (cemiplimab) in P-III Trial for Cervical Cancer

Published: Mar 15, 2021 | Tags: Regeneron and Sanofi, Report, Results, Libtayo (cemiplimab), P-III Trial, Cervical Cancer

Eli Lilly Report Result of Donanemab in P-II TRAILBLAZER-ALZ Study for Alzheimer’s Disease

Published: Mar 15, 2021 | Tags: Eli Lilly, Report, Result, Donanemab, P-II TRAILBLAZER-ALZ, Study, Alzheimer’s Disease

The post PharmaShots Weekly Snapshots (Mar 15 – 19, 2021) first appeared on PharmaShots.